General Catalyst is a venture capital firm established in 2000, headquartered in Cambridge, Massachusetts, with additional offices in North America and Europe. The company specializes in early-stage and growth equity investments, focusing on technology-driven businesses. It invests across various sectors, including consumer internet, enterprise software, fintech, health assurance, and crypto. General Catalyst provides not only capital but also mentorship and resources to accelerate the growth of its portfolio companies. To date, it has managed eight venture capital funds, totaling approximately $3.75 billion in capital commitments.
Two South Park Street Suite 100 San Francisco, CA 94107
434 Broadway Sixth Floor New York, NY 10013
564 University Avenue Palo Alto, CA 94301
20 University Road Fourth Floor Cambridge, MA 02138
Adrian Abeijon
Investor
Mark Allen
CFO
Neeraj Arora
Managing Director, Investment Team
Juliet Bailin
Principal
Marc Bhargava
Managing Director
Chris Bischoff
Managing Director
Larry Bohn
Managing Director
Teresa Carlson
President, General Catalyst Institute
Kenneth Chenault
Chairman and Managing Director
Quentin Clark
Managing Director
Mark Crane
Partner
Christopher Davis
Partner
Kyle Doherty
Managing Director
Nick van Eck
Partner
Mina Hsiang
Associate
Nmachi Jidenma
Partner
Christopher Kauffman
Principal
Genevieve Kinney
Principal
Zak Kukoff
Principal
Paul Kwan
Managing Director
Viet Le
Partner
Roy Mabrey
Partner, Investment Team
Holly Maloney McConnell
Managing Director
Karanveer Mohan
Managing Director, Investment Team
Deep Nishar
Managing Director and Member of the Management Committee
Dipchand Nishar
Managing Director
Reva Nohria
Investor
Trevor Oelschig
Managing Director
Tyler Olkowski
Investor
Pranay Orugunta
Healthcare Investor
Mo Punjwani
Associate, Investments
Candace Richardson
Principal
Brian Ru
Principal
Pranav Singhvi
Managing Director
Bill Skarinka
Associate
Alex Tran
Managing Director, Investments
Catherine Tu
Partner, Investment Team
Elena Viboch
Partner
Andrea Wang
Principal, Early Stage Investment
Nathaniel Levy-Westhead
Partner, Investment Team
Past deals in Healthcare
RISA Labs
Seed Round in 2025
RISA Labs utilizes Multi-Agent Systems to reimagine healthcare, enhancing efficiency and elevating patient care. The company's MAS interface sparks innovation in healthcare, aiming to make healthcare administration more intelligent, responsive, and centered around patients.
Thatch
Series B in 2025
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Stance Health
Pre Seed Round in 2025
Stance Health is a health technology company specializing in musculoskeletal (MSK) care. It develops a health and wellness platform that integrates medical science and technology to deliver evidence-based orthopedic rehabilitation. The company focuses on performance recovery and prevention, offering personalized programs for individuals with MSK conditions. Services include advanced diagnostic tools, tailored rehabilitation plans, and ongoing assessments, helping patients recover, prevent injuries, and improve their overall physical well-being.
Sohar Health
Seed Round in 2025
Sohar Health is a platform focused on enhancing the operations of behavioral health companies through a cloud-based eligibility verification and utilization reporting system. It provides an API-driven solution that facilitates eligibility verification and employs AI-powered medical coding to streamline manual workflows. The platform includes features designed to automate processes, manage eligibility files securely, and offer utilization analytics and reporting. This comprehensive approach enables digital health providers to scale their operations efficiently and increase revenue.
Taxo
Seed Round in 2025
Taxo is a technology company specializing in healthcare administration. It employs proprietary AI models to automate various administrative processes, including retrieving clinical guidelines, verifying insurance coverage, and managing patient records. The company's platform adheres to strict data protection standards, allowing hospitals to concentrate more on patient care.
Arlo Health
Seed Round in 2025
Developer of a health insurance platform designed to provide affordable and employee-centric healthcare coverage. The company offers AI-powered plan management, concierge support, and predictable renewal rates, enabling businesses to control costs, enhance employee satisfaction, and simplify benefits administration.
Eikon Therapeutics
Series D in 2025
Eikon Therapeutics, Inc. is a biopharmaceutical company based in Hayward, California, focused on developing innovative treatments for chronic and life-threatening diseases. Founded in 2019, the company employs advanced super-resolution microscopy and live-cell imaging techniques to discover drugs targeting previously intractable proteins. By integrating biology, engineering, and chemistry, Eikon Therapeutics aims to enhance the understanding of cellular processes and improve drug discovery efficiency. Its proprietary platforms allow for the sensitive identification of compound-protein interactions, enabling the direct measurement of how chemical compounds affect individual proteins in live cells. This novel approach seeks to unlock new therapeutic opportunities and expand the company's pipeline of potential medications.
Fay
Series B in 2025
Fay is a company that connects individuals with dietitians covered by their health insurance, promoting improved dietary habits and overall well-being. It offers consulting services focused on medical nutrition therapy, enabling clients to select a dietitian and arrange either virtual or in-person consultations. Fay designs personalized nutrition plans tailored to each client's needs and works with insurance providers to ensure that these services are accessible and affordable. By facilitating customized nutrition counseling, Fay aims to enhance food-related health outcomes for its clients.
Delve
Seed Round in 2025
Delve is a company that focuses on simplifying the process of achieving HIPAA compliance for its clients. It has developed a tracking platform that assists organizations in monitoring their compliance journey. The platform includes features such as work deployment, paperwork automation, and compliance monitoring. By offering continuous integration and continuous deployment (CI/CD) pipelines, Delve enables clients to efficiently manage infrastructure updates directly from their code repositories. This approach helps organizations streamline their documentation processes, making it easier to meet regulatory requirements.
Manas AI
Seed Round in 2025
Manas AI uses proprietary AI, generative computational chemistry, and best-in-class biology to reduce the time and expense of traditional medicinal development while also revolutionizing cancer and rare illness treatments.
Neko Health
Series B in 2025
Neko Health is a Swedish health-tech company focused on enhancing healthcare through prevention and early detection of diseases. It has developed innovative medical scanning technology that enables comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By leveraging sensor technology and artificial intelligence, Neko Health aims to reduce the prevalence of common diseases and their associated healthcare costs. The company provides doctors and clinicians with tools for flexible and cost-effective examinations, ultimately aiming to improve the quality of healthcare and promote proactive health management.
Hippocratic AI
Series B in 2025
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Orange Health Labs
Venture Round in 2024
Orange Health Labs is a health tech startup focused on providing diagnostic laboratory services that facilitate remote healthcare delivery. By enabling doctors to conduct tests and diagnostics from a patient's home, the company aims to enhance the accessibility and efficiency of healthcare. Its patient-centric approach allows individuals to avoid clinic visits for blood tests and other diagnostic procedures by offering affordable home sample collection and timely access to test results. This model not only minimizes the inconvenience of traditional healthcare services but also significantly reduces wait times for critical health assessments, ultimately making healthcare more seamless and responsive to consumer needs.
Soda Health
Series B in 2024
Soda Health is a healthcare technology company founded in 2021 and based in Chicago, Illinois. The company focuses on addressing health inequities by leveraging social determinants of health. It offers a technology platform designed to assist individuals in identifying, accessing, and funding the resources necessary for a healthy life. By providing a system for administering and reimbursing personalized benefits, Soda Health enables customers to effectively bridge the gap between medical claims and retail payments, ultimately promoting better health outcomes.
Endo Health
Seed Round in 2024
Endo Health specializes in developing an AI-driven platform aimed at managing type 2 diabetes through gamification. The company's innovative approach features a virtual assistant designed to guide patients through the various stages of diabetes management. By utilizing real-time data from continuous glucose monitors, Endo Health's platform enables users to track their blood sugar levels and activity, promoting healthier lifestyle choices in an engaging and enjoyable manner. This solution seeks to simplify the management of chronic diabetes, making it more accessible and effective for patients.
OASYS NOW
Seed Round in 2024
OASYS NOW is a technology platform focused on improving the treatment journey for chronic patients by efficiently connecting them with relevant clinical trials tailored to their unique health data. The platform utilizes advanced algorithms to match patients with suitable global clinical trials, thereby increasing their opportunities for personalized treatment options. OASYS NOW emphasizes patient privacy through a privacy-by-design approach while harnessing extensive medical data to enhance health outcomes. Additionally, the company provides secure data-sharing solutions and ethical data processing systems aimed at organizations in the health and genomics sectors, ensuring a robust and secure infrastructure for sensitive health information.
Medeloop
Series A in 2024
Medeloop is a pioneering platform that enhances medical research through advanced artificial intelligence and a robust data linkage infrastructure. It integrates and analyzes vast amounts of health data, transforming it into a graph database that provides deeper insights and connectivity. This technology streamlines the clinical research process by offering research hypotheses for underexplored diseases, thereby enabling researchers to publish findings more efficiently. Additionally, Medeloop features a patient-facing application that empowers individuals to monitor their health information and actively contribute to significant medical research. By facilitating collaboration among patients, providers, and researchers, Medeloop aims to accelerate the discovery of biomarkers and potential drug targets, ultimately improving treatment development and saving lives.
Pharos
Seed Round in 2024
Pharos is a Hospitals and Health Care tech that helps with quality reporting without any manual chart review.
Alpha9 Theranostics
Series C in 2024
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies. The company is creating a strong pipeline of radiopharmaceuticals to target solid and hematologic malignancies. Its systematic approach to radiotherapeutic design is fueled by a toolbox of technologies and chemistries, which offers broad potential for expansion into a multitude of oncology targets. Alpha9 Theranostics was founded in 2019 and is headquartered in Vancouver, Canada.
HealthEx
Series A in 2024
HealthEx operates a healthcare data-sharing platform that aims to create networks among patients, health systems, and life sciences. The company is dedicated to developing infrastructure for a participatory health data ecosystem that emphasizes digital rights, patient consent, and transparency. By prioritizing patient-centric collaboration, HealthEx seeks to enhance the sharing of health data, thereby facilitating advancements in precision medicine. The platform focuses on empowering patients to mediate their own health data, fostering a collaborative environment that benefits both individuals and healthcare providers.
Primus
Seed Round in 2024
Primus helps elderly people slow the aging process by eliminating loneliness and achieving 'Zero Falls'. We ensure that we are proactive rather than reactive by conducting a series of examinations prior to onboarding elders so that they can be monitored by our in-house medical staff under a personalized care plan.
Astrix Health
Pre Seed Round in 2024
Astrix Health, based in San Francisco, New York, and London, specializes in AI-driven procurement solutions for healthcare providers. The company employs generative AI to analyze vast amounts of data, helping providers secure favorable terms on recurring medical supplies, equipment, and pharmaceutical orders. Astrix's team, comprising experts from Palantir, Oxford, Duke Health, and MedStar Health, aggregates and normalizes data from millions of sources to deliver actionable pricing insights. The company operates globally, backed by Y Combinator.
Maven Clinic
Series F in 2024
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
Taxo
Seed Round in 2024
Taxo is a technology company specializing in healthcare administration. It employs proprietary AI models to automate various administrative processes, including retrieving clinical guidelines, verifying insurance coverage, and managing patient records. The company's platform adheres to strict data protection standards, allowing hospitals to concentrate more on patient care.
Thatch
Series A in 2024
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Doccla
Series B in 2024
Doccla is a provider of virtual ward services that focuses on shifting patient care from hospitals to home settings. The company partners with care organizations to facilitate early patient discharge and reduce hospital readmissions through remote monitoring using advanced medical devices. By onboarding patients at home with the necessary monitoring equipment, Doccla employs a mobile team of healthcare professionals, including nurses and doctors, to oversee patient care. This approach not only ensures that patients receive timely and effective treatment but also aims to enhance care quality while lowering associated costs. Originally developed as part of a research initiative for the NHS, Doccla's innovative service has been successfully implemented in collaboration with Northampton General Hospital.
Clarium Health
Venture Round in 2024
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.
MD Ally
Series A in 2024
MD Ally, Inc. is a company focused on enhancing telemedicine services, specifically within the realm of emergency medical services. Incorporated in 2020 and based in Philadelphia, Pennsylvania, the company has developed a triage solution that addresses non-emergency care gaps. Its platform streamlines access between public safety practitioners and healthcare providers, enabling the triage of non-life-threatening medical concerns through telehealth. This allows patients to receive virtual medical and behavioral healthcare, in-network follow-up care, alternative transportation, and social services without the need for costly emergency service dispatch. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to provide efficient and effective care solutions for both patients and EMS providers.
HarmonyCares
Venture Round in 2024
HarmonyCares specializes in delivering comprehensive medical care directly to clients in their homes. The company focuses on individuals with multiple chronic conditions, cognitive challenges, and psychosocial issues, offering a range of services that include primary and specialty care programs, home health services, hospice and palliative care, as well as diagnostic services such as radiology and laboratory testing. By providing high-quality, integrated care in a comfortable setting, HarmonyCares aims to meet the diverse health needs of patients, particularly the elderly, while also supplying durable medical equipment to enhance their home care experience. Rebranded from U.S. Medical Management in 2022, HarmonyCares emphasizes a physician-driven approach to ensure optimal health outcomes for its clients.
Adonis
Series B in 2024
Adonis is a healthcare revenue intelligence and automation platform that addresses operational challenges affecting revenue cycle management (RCM). Healthcare providers frequently fail to collect over 15% of their entitled revenue due to systemic issues within traditional RCM processes. Adonis utilizes data science and artificial intelligence to identify vulnerabilities and streamline operations, enhancing claim accuracy and detecting underpayments. By automating routine tasks, the platform minimizes administrative burdens, allowing medical providers to concentrate on patient care while optimizing financial outcomes. Through these innovative solutions, Adonis aims to improve revenue collection for healthcare organizations.
Better Health
Series A in 2024
Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.
Fay
Series A in 2024
Fay is a company that connects individuals with dietitians covered by their health insurance, promoting improved dietary habits and overall well-being. It offers consulting services focused on medical nutrition therapy, enabling clients to select a dietitian and arrange either virtual or in-person consultations. Fay designs personalized nutrition plans tailored to each client's needs and works with insurance providers to ensure that these services are accessible and affordable. By facilitating customized nutrition counseling, Fay aims to enhance food-related health outcomes for its clients.
Triomics
Series A in 2024
Triomics is a generative AI-powered platform focused on enhancing the efficiency of clinical trials, particularly in the field of oncology. The company aims to accelerate trial enrollment and improve healthcare operations by addressing operational inefficiencies in data collection and patient recruitment. Leveraging its advanced AI technology, which is trained to understand health records and medical terminology, Triomics facilitates a more streamlined approach to clinical research. Its platform supports pharmaceutical companies and contract research organizations in conducting rapid and cost-effective trials, ultimately advancing oncology research and care.
Blackwell Security
Seed Round in 2024
Blackwell Security offers managed security operations for healthcare organizations to deliver complete protection and rapid response. The company aids in enhancing an organization’s cybersecurity maturity by providing specialized guidance to streamline and bolster its security practices, address gaps in its cyber compliance posture, and proactively facilitate improvements across its program.
Hona AI
Seed Round in 2024
Hona AI is an AI data platform that collects and maintains healthcare history and records of patients.
Transcarent
Series D in 2024
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.
InStride Health
Series B in 2024
InStride Health is an outpatient care platform focused on delivering evidence-based treatment for pediatric anxiety and obsessive-compulsive disorder (OCD). The company offers a tailored virtual care journey that includes individual and group therapy, coaching, and medication management, all facilitated by a coordinated team of psychiatrists, therapists, and coaches. This approach ensures that children and teenagers receive effective, accessible, and affordable care, keeping them engaged throughout the treatment process. By prioritizing evidence-based practices, InStride Health aims to enhance the mental well-being of young patients and their families.
Hippocratic AI
Series A in 2024
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Empathy
Series B in 2024
Empathy is a platform designed to assist families in navigating the complexities of loss. By integrating technology with human support, Empathy offers a digital companion application that empowers bereaved families. The application serves as a comprehensive support system, guiding users through the emotional, financial, legal, and logistical challenges that arise after the death of a loved one. Through its innovative approach, Empathy aims to alleviate some of the burdens faced by families during difficult times.
Chamber Cardio
Seed Round in 2024
Chamber Cardio is a healthcare platform focused on enhancing cardiovascular health services by facilitating the transition of cardiologists to value-based care. The company provides a range of services, including panel management with real-time updates, financial metrics, and clinical data consolidated into a user-friendly dashboard. Additionally, it offers software support to manage complex patient cases and engages in value-based contracting. This comprehensive approach aims to improve treatment accessibility for patients and streamline operations within the healthcare sector.
Overjet
Series C in 2024
Overjet, Inc. is a leading developer of artificial intelligence software designed to analyze dental clinical data, enhancing the quality of patient care in dental practices. Founded by experts from MIT and Harvard University in 2018 and based in Allston, Massachusetts, Overjet offers clinical optimization software that assesses practice performance and identifies growth opportunities. Additionally, its utilization software automates the review of claims to pinpoint over- and under-utilization, thereby facilitating appropriate patient care at reduced costs. The company's FDA-cleared technology serves as an objective standard for oral health decisions, enabling dentists to accurately detect pathologies and effectively educate patients. Through its innovative AI solutions, Overjet aims to empower dental providers and payers to improve patient outcomes in the dental industry.
Finni Health
Series A in 2024
Finni enables passionate ABA providers to start and grow their own in-network practices. We empower providers to go independent in as little as 30 days and offer a complete full-stack solution to run their practice.
Fabric
Series A in 2024
Fabric is a health tech company that enables healthcare providers to deliver faster, higher quality, and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff.
Genial Care
Venture Round in 2024
Genial Care is a company based in São Paulo, Brazil, dedicated to providing specialized services for children with autism and developmental difficulties. Founded in 2020, it operates a network of both physical and digital clinics that offer real-time monitoring of the child's progress. In addition to direct care, Genial Care provides training programs for parents and therapists, ensuring personalized attention and support tailored to the needs of each child. The company's holistic approach aims to transform the lives of children with autism and their families, helping them to achieve their full potential.
Summa Health
Acquisition in 2024
Summa Health is a comprehensive healthcare provider that focuses on delivering integrated and coordinated care across a network of facilities. This network includes hospitals, community health centers, and a health plan, alongside a physician-hospital organization and a multi-specialty physician organization. Summa Health emphasizes personalized patient-centered care, particularly through its specialized Cancer Centers, which utilize advanced treatment technology and medical expertise to support whole-person healing. Additionally, the organization is involved in research and operates various foundations to enhance healthcare delivery and improve patient outcomes.
Harbor Health
Series A in 2024
Harbor Health is a multi-specialty clinic group based in Austin, Texas, founded in 2022. The organization focuses on delivering personalized, patient-centered healthcare by utilizing technology to enhance the patient experience. Harbor Health offers a collaborative approach to healthcare, working closely with individuals to understand their health goals and providing access to specialists when necessary. The clinic provides a variety of services, including primary care, chronic disease management, behavioral health, and overall wellness. Patients benefit from same-day and virtual appointment options, as well as conveniently located clinics, ensuring that healthcare is accessible and responsive to their needs.
Devoted
Series E in 2023
Devoted Health, established in 2017 and headquartered in Newton, Massachusetts, specializes in providing comprehensive healthcare solutions for Medicare beneficiaries in the United States. The company offers Medicare Advantage plans, along with personalized care through dedicated health guides, both in-person and virtually. Devoted Health aims to improve the health and well-being of older Americans by combining access to top local providers, virtual and in-home care through Devoted Medical, and advanced technology to deliver tailored healthcare experiences.
Phare Health
Seed Round in 2023
Phare Health operates an AI-driven platform that streamlines healthcare administration. It converts unstructured clinical notes into structured data, empowering hospitals to manage resources effectively, recover costs accurately, and ensure proper reimbursement.
Layer Health
Seed Round in 2023
Layer Health is a technology company specializing in AI-driven healthcare information solutions. It develops an AI-powered platform designed to help healthcare providers extract valuable insights from patient data, enabling them to make informed decisions, enhance patient care, and improve overall efficiency. The platform focuses on processing unstructured data from clinical, administrative, and research sources, transforming it into actionable insights to support providers in their clinical and operational tasks.
Commure
Venture Round in 2023
Commure, Inc. is an innovative company that has developed an open platform aimed at healthcare software developers. Founded in 2017 and headquartered in San Francisco, California, with additional offices in Boston, Montreal, and Bogota, Commure provides a comprehensive developer platform that facilitates the creation and deployment of next-generation healthcare applications. This platform is built on the open HL7 FHIR standard, offering essential features such as an FHIR API server, security framework, event service bus, EHR integration, and more. By unifying disparate datasets and delivering meaningful insights, Commure enhances performance and fosters collaboration among doctors, nurses, and patients, ultimately empowering the healthcare ecosystem to improve care delivery. The company's commitment to interoperability and innovation positions it as a leader in the healthcare technology space.
Lottie
Series A in 2023
Lottie is a company focused on transforming the care sector by empowering care seekers through a comprehensive booking platform for care homes. The platform simplifies the search process for families and retirees by providing access to essential resources such as meditation, club booking, outdoor activities, and detailed research on nearby care homes. Additionally, Lottie's platform facilitates digital communication and negotiation of online resident agreements, enhancing the overall experience for users in their quest for suitable care homes and retirement living communities.
Evvy
Series A in 2023
Evvy is a company focused on improving female health by offering at-home vaginal microbiome tests. These tests utilize metagenomic sequencing to analyze symptoms and identify risks associated with important health issues. By providing personalized reports, Evvy aims to empower women with insights about their bodies, thereby addressing the gender health gap and enhancing overall health outcomes for women.
Cartwheel
Series A in 2023
Cartwheel is a provider of mental health support specifically designed for the school community, founded in 2022 and based in Cambridge, Massachusetts. The company addresses the growing mental health crisis among students by offering evidence-based services from licensed clinicians. Cartwheel partners with schools to facilitate rapid access to mental health assessments, therapy, and medication evaluations, aiming to empower school staff, alleviate family stress, and enhance overall student mental health outcomes. Its program is compliant with FERPA and HIPAA regulations, ensuring it meets the unique needs of educational institutions in the aftermath of the COVID-19 pandemic. By focusing on creating a supportive environment, Cartwheel helps schools become places where every student can thrive.
Medeloop
Seed Round in 2023
Medeloop is a pioneering platform that enhances medical research through advanced artificial intelligence and a robust data linkage infrastructure. It integrates and analyzes vast amounts of health data, transforming it into a graph database that provides deeper insights and connectivity. This technology streamlines the clinical research process by offering research hypotheses for underexplored diseases, thereby enabling researchers to publish findings more efficiently. Additionally, Medeloop features a patient-facing application that empowers individuals to monitor their health information and actively contribute to significant medical research. By facilitating collaboration among patients, providers, and researchers, Medeloop aims to accelerate the discovery of biomarkers and potential drug targets, ultimately improving treatment development and saving lives.
Georgiamune
Series A in 2023
Georgiamune is an immunotherapy company dedicated to advancing oncology treatments. The firm specializes in next-generation immunotherapeutic and homeostatic therapies aimed at addressing cancer and autoimmune diseases. By focusing on innovative approaches, Georgiamune seeks to enhance patient recovery from cancer, contributing to significant breakthroughs in the field of immunotherapy.
Neko Health
Series A in 2023
Neko Health is a Swedish health-tech company focused on enhancing healthcare through prevention and early detection of diseases. It has developed innovative medical scanning technology that enables comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By leveraging sensor technology and artificial intelligence, Neko Health aims to reduce the prevalence of common diseases and their associated healthcare costs. The company provides doctors and clinicians with tools for flexible and cost-effective examinations, ultimately aiming to improve the quality of healthcare and promote proactive health management.
Berry Health
Pre Seed Round in 2023
Berry Health is a consumer health startup dedicated to improving lives by addressing under-served and stigmatized medical conditions. The company specializes in remote diagnosis and treatment for chronic health issues through online private medical consultations. Berry Health provides prescription medications and nationwide delivery, empowering patients to take control of their health. The services offered cover a wide range of conditions, including dermatology, mental health, sexual health, hair loss, and more, benefiting both men and women. By focusing on enhancing patient agency, Berry Health aims to promote better health outcomes, reduce inflammation and pain, optimize immunity, and improve brain health.
Adonis
Series A in 2023
Adonis is a healthcare revenue intelligence and automation platform that addresses operational challenges affecting revenue cycle management (RCM). Healthcare providers frequently fail to collect over 15% of their entitled revenue due to systemic issues within traditional RCM processes. Adonis utilizes data science and artificial intelligence to identify vulnerabilities and streamline operations, enhancing claim accuracy and detecting underpayments. By automating routine tasks, the platform minimizes administrative burdens, allowing medical providers to concentrate on patient care while optimizing financial outcomes. Through these innovative solutions, Adonis aims to improve revenue collection for healthcare organizations.
Hippocratic AI
Seed Round in 2023
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Memora Health
Venture Round in 2023
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.
CTRL Therapeutics
Seed Round in 2023
CTRL Therapeutics is a biotechnology company based in Toronto, Canada, focused on the development of cell therapies and innovative diagnostic solutions. The company has created a microfluidic platform that enhances the detection of rare circulating tumor cells. This technology is integral to the development of a cancer liquid biopsy test, which aims to predict how patients will respond to targeted therapies. By enabling the evaluation of protein expression on tumor cells, CTRL Therapeutics seeks to provide valuable insights for doctors in tailoring treatment plans for cancer patients.
Finni Health
Seed Round in 2023
Finni enables passionate ABA providers to start and grow their own in-network practices. We empower providers to go independent in as little as 30 days and offer a complete full-stack solution to run their practice.
MD Ally
Seed Round in 2023
MD Ally, Inc. is a company focused on enhancing telemedicine services, specifically within the realm of emergency medical services. Incorporated in 2020 and based in Philadelphia, Pennsylvania, the company has developed a triage solution that addresses non-emergency care gaps. Its platform streamlines access between public safety practitioners and healthcare providers, enabling the triage of non-life-threatening medical concerns through telehealth. This allows patients to receive virtual medical and behavioral healthcare, in-network follow-up care, alternative transportation, and social services without the need for costly emergency service dispatch. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to provide efficient and effective care solutions for both patients and EMS providers.
Maribel Health
Series A in 2023
Maribel Health focuses on developing and operating advanced clinical care models that deliver healthcare services in home and community settings. The company aims to enhance the overall capacity of health systems and improve patient access by offering innovative home-based care solutions. In addition to its care models, Maribel Health provides assessment and planning services for home and community-based care, addressing the specific needs of local markets and healthcare organizations. Through these initiatives, the company seeks to facilitate better healthcare delivery and support the strategic goals of its partners.
Faro Health
Series A in 2023
Faro Health is a developer of a cloud-based medical platform aimed at addressing the complexities of clinical trials. The platform standardizes, automates, and streamlines various challenges associated with clinical studies. By utilizing an integrated clinical development environment, Faro Health simplifies the design and authoring of complex clinical protocols. This system leverages advanced digital protocols to provide intuitive insights during the authoring process, allowing clinical researchers to focus on critical decisions that enhance clinical value while minimizing administrative burdens.
Paradigm
Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.
Breathe Well-being
Series B in 2023
Breathe Well-being is a health technology startup based in India that focuses on managing and preventing type 2 diabetes through a clinically proven program. The company assists individuals with chronic conditions, such as diabetes, in their weight loss efforts by providing personalized one-on-one coaching. Users receive guidance on tracking their weight, meals, and activities, while also learning cognitive behavioral therapy techniques to manage stress. Breathe Well-being promotes long-term healthy habits through individual lifestyle tracking and personalized counseling, complemented by social interactions and community challenges. The program has successfully helped over 10,000 members lose weight, lower blood sugar levels, and reduce the risk of health complications.
Genial Care
Grant in 2023
Genial Care is a company based in São Paulo, Brazil, dedicated to providing specialized services for children with autism and developmental difficulties. Founded in 2020, it operates a network of both physical and digital clinics that offer real-time monitoring of the child's progress. In addition to direct care, Genial Care provides training programs for parents and therapists, ensuring personalized attention and support tailored to the needs of each child. The company's holistic approach aims to transform the lives of children with autism and their families, helping them to achieve their full potential.
Fay
Seed Round in 2023
Fay is a company that connects individuals with dietitians covered by their health insurance, promoting improved dietary habits and overall well-being. It offers consulting services focused on medical nutrition therapy, enabling clients to select a dietitian and arrange either virtual or in-person consultations. Fay designs personalized nutrition plans tailored to each client's needs and works with insurance providers to ensure that these services are accessible and affordable. By facilitating customized nutrition counseling, Fay aims to enhance food-related health outcomes for its clients.
Disclo
Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.
Vial
Series B in 2022
Vial is a biotech company that focuses on enhancing the efficiency and affordability of clinical trials. By partnering with clinics, Vial transforms them into clinical trial research sites equipped with the necessary technology and infrastructure. The company's platform manages various aspects of clinical trials, including administrative tasks, data entry, patient scheduling and recruitment, invoicing, and compliance. This comprehensive approach allows biotechnology companies to navigate different phases of drug development more effectively while also providing partner clinics with opportunities to increase their revenue. Vial's emphasis on automation and advanced technologies positions it as a key player in the evolution of clinical trial processes.
Vial
Series A in 2022
Vial is a biotech company that focuses on enhancing the efficiency and affordability of clinical trials. By partnering with clinics, Vial transforms them into clinical trial research sites equipped with the necessary technology and infrastructure. The company's platform manages various aspects of clinical trials, including administrative tasks, data entry, patient scheduling and recruitment, invoicing, and compliance. This comprehensive approach allows biotechnology companies to navigate different phases of drug development more effectively while also providing partner clinics with opportunities to increase their revenue. Vial's emphasis on automation and advanced technologies positions it as a key player in the evolution of clinical trial processes.
Maven Clinic
Series E in 2022
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
Apiiro
Series B in 2022
Apiiro LLC is a code security startup based in New York that specializes in identifying security vulnerabilities within applications. The company has developed a Code Risk Platform that utilizes code behavior analysis to help organizations detect issues such as weak encryption and vulnerabilities to malware injection, as well as to ensure compliance with regulatory standards. By providing security and development teams with comprehensive visibility and actionable insights, Apiiro enables them to proactively address risks before deployment. The platform is particularly valuable to large enterprises in sectors such as gaming, healthcare, software development, and banking, allowing them to accelerate their delivery processes while effectively managing product risk. Founded in 2019, Apiiro aims to enhance the security of the software supply chain through its innovative approach to risk remediation.
Doccla
Series A in 2022
Doccla is a provider of virtual ward services that focuses on shifting patient care from hospitals to home settings. The company partners with care organizations to facilitate early patient discharge and reduce hospital readmissions through remote monitoring using advanced medical devices. By onboarding patients at home with the necessary monitoring equipment, Doccla employs a mobile team of healthcare professionals, including nurses and doctors, to oversee patient care. This approach not only ensures that patients receive timely and effective treatment but also aims to enhance care quality while lowering associated costs. Originally developed as part of a research initiative for the NHS, Doccla's innovative service has been successfully implemented in collaboration with Northampton General Hospital.
Redesign Health
Series C in 2022
Redesign Health is a company founded in 2018 that focuses on driving innovation in the healthcare sector. It develops technologies, tools, and insights designed to lower barriers to change within the industry. Redesign Health collaborates with exceptional founders to create and support over two dozen companies that have collectively impacted more than ten million lives across various healthcare domains, including cancer care, teleradiology, COVID-19 testing, and metabolic health. By fostering the growth of diverse healthcare solutions, Redesign Health aims to enhance the overall efficiency and effectiveness of healthcare delivery.
Certify
Series A in 2022
CertifyOS is a data intelligence platform focused on streamlining provider data management within the U.S. healthcare system. It provides an API-first and user interface agnostic solution that automates the entire provider network management lifecycle, including licensing, credentialing, and health plan enrollment. By integrating with numerous primary sources, CertifyOS offers near real-time verification and monitoring, facilitating efficient management of provider networks for insurance companies and virtual care providers. The platform aims to simplify and enhance the scalability of provider networking, positioning itself as a comprehensive resource for these critical operational needs.
Plume Clinic
Series B in 2022
Plume is a health tech company for the transgender community. The company focuses on radically increasing access to care, medication, and products for the trans community, supporting a bold, authentic and healthy lifestyle. Its vision is to make gender-affirming care available to anyone until it transforms healthcare for every trans life.
Fractyl Health
Series F in 2022
Fractyl Health, based in Lexington, Massachusetts, specializes in developing innovative medical device solutions for metabolic diseases, particularly type 2 diabetes and obesity. The company’s primary offering, Revita DMR, is a minimally invasive therapy that utilizes hydrothermal ablation to rejuvenate the duodenal lining, which can become compromised due to high-fat and high-sugar diets. By focusing on durable disease-modifying therapies rather than just symptomatic management, Fractyl Health aims to address the underlying causes of metabolic diseases, improving patient outcomes and reducing healthcare burdens. Founded in 2010 and originally named MedCatalyst, Inc., the company envisions a future where less invasive, device-based therapies provide effective solutions for large populations affected by metabolic disorders.
Homeward
Series B in 2022
Homeward is focused on transforming healthcare services for the 60 million Americans residing in rural areas. The company utilizes multidisciplinary care teams that operate both virtually and through mobile care units, ensuring comprehensive and accessible healthcare. Homeward employs in-home remote monitoring technology to enhance patient connections to high-quality and affordable care. By partnering with Medicare Advantage plans, the organization assumes full financial risk for its members, aiming to improve health outcomes while reducing costs. Through these initiatives, Homeward seeks to provide effective support to Medicare-eligible beneficiaries in underserved communities.
Lottie
Seed Round in 2022
Lottie is a company focused on transforming the care sector by empowering care seekers through a comprehensive booking platform for care homes. The platform simplifies the search process for families and retirees by providing access to essential resources such as meditation, club booking, outdoor activities, and detailed research on nearby care homes. Additionally, Lottie's platform facilitates digital communication and negotiation of online resident agreements, enhancing the overall experience for users in their quest for suitable care homes and retirement living communities.
August Health
Series A in 2022
August Health is a high-growth company focused on enhancing the quality of care for older adults living in senior living communities. The company has developed a healthcare platform that collects data to offer insights into the wellness of seniors, facilitating connections to clinical and social support services. This innovative approach aims to help aging individuals reduce their annual long-term care costs while improving their overall well-being. With a background in founding successful ventures and managing extensive engineering and clinical teams, August Health is dedicated to transforming healthcare for vulnerable older adults.
Examedi
Series A in 2022
Examedi is a healthcare startup that facilitates at-home medical services by connecting patients with independent nurses and lab technicians. Through its telemedicine platform, Examedi allows patients to book diagnostic tests and examinations, including blood tests, pregnancy tests, general checkups, and COVID tests. This service prioritizes accessibility and affordability, ensuring that patients can receive necessary medical care in the comfort of their homes. By coordinating the schedules of healthcare providers with patient needs, Examedi aims to enhance the convenience and efficiency of healthcare delivery.
Flexpa
Seed Round in 2022
Flexpa is a healthcare technology company founded in 2021 and based in San Francisco, California. It specializes in developing a platform that allows digital health applications to connect with patient access APIs and integrate claims histories. By digitizing data collected from various healthcare providers, Flexpa creates analytics dashboards that enable healthcare professionals to track individual and group patient outcomes. This integration of diagnostic tests and lab reports helps providers make informed decisions regarding treatment plans and pharmaceutical options, ultimately aiming to enhance healthcare outcomes.
Sesame
Series B in 2022
Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.
Capital Rx
Series C in 2022
Capital Rx, Inc. is a pharmacy benefit manager that specializes in managing self-insured prescription benefit plans for employers, unions, and government entities. Founded in 2017 and headquartered in New York, the company aims to transform the pricing and administration of prescriptions in the U.S. through its innovative Clearinghouse Model, which enhances transparency in the pharmacy supply chain and reduces costs for employer groups. By integrating various components of the pharmacy ecosystem into a single platform, Capital Rx improves administrative workflows, clinical oversight, and patient-provider coordination. This approach not only increases drug price visibility but also focuses on enhancing patient outcomes and healthcare efficiency, ultimately fostering better engagement between healthcare providers and patients.
CHARM Therapeutics
Series A in 2022
CHARM Therapeutics is focused on developing innovative medicines using advanced 3D deep learning and drug discovery technologies. The company's platform aims to address undruggable disease targets, providing healthcare professionals with effective treatment options for challenging medical conditions. By leveraging cutting-edge technology, CHARM Therapeutics seeks to create transformative therapies that have the potential to significantly improve patient outcomes.
Orange Health Labs
Series B in 2022
Orange Health Labs is a health tech startup focused on providing diagnostic laboratory services that facilitate remote healthcare delivery. By enabling doctors to conduct tests and diagnostics from a patient's home, the company aims to enhance the accessibility and efficiency of healthcare. Its patient-centric approach allows individuals to avoid clinic visits for blood tests and other diagnostic procedures by offering affordable home sample collection and timely access to test results. This model not only minimizes the inconvenience of traditional healthcare services but also significantly reduces wait times for critical health assessments, ultimately making healthcare more seamless and responsive to consumer needs.
Mirvie
Series B in 2022
Mirvie is a biotech company focused on developing non-invasive tests aimed at improving maternal-fetal health. Founded in 2018 and based in South San Francisco, California, Mirvie offers a medical diagnostic platform that provides actionable insights for mothers and families throughout their pregnancy journey. The company's innovative predictive tests help medical practitioners identify at-risk pregnancies, allowing for timely interventions and enhanced management of pregnancy-related concerns. By prioritizing safety and health, Mirvie seeks to empower families with the information necessary for better pregnancy outcomes.
Osmind
Series B in 2022
Osmind Inc., established in 2020 and headquartered in San Jose, California, specializes in designing and developing healthcare software tailored for mental health providers and their patients. The company, led by a team of scientists, technologists, and psychiatrists, aims to advance evidence-based medicine for individuals with moderate to severe mental health conditions. Osmind's core product is a mental health operating platform, which includes an electronic health record system designed for interventional treatment workflows. This platform offers tools such as journaling and assistance with health plan reimbursement, enabling clinicians to explore novel therapeutic approaches and precision psychiatry, ultimately enhancing patient care.
Loop
Series B in 2022
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.
MD Ally
Seed Round in 2022
MD Ally, Inc. is a company focused on enhancing telemedicine services, specifically within the realm of emergency medical services. Incorporated in 2020 and based in Philadelphia, Pennsylvania, the company has developed a triage solution that addresses non-emergency care gaps. Its platform streamlines access between public safety practitioners and healthcare providers, enabling the triage of non-life-threatening medical concerns through telehealth. This allows patients to receive virtual medical and behavioral healthcare, in-network follow-up care, alternative transportation, and social services without the need for costly emergency service dispatch. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to provide efficient and effective care solutions for both patients and EMS providers.
Alinea Health
Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.
Avant-garde Health
Series A in 2022
Avant-garde Health, Inc. is a healthcare solutions company based in Allston, Massachusetts, founded in 2014. It specializes in developing a web-based analytics platform that assists hospitals and healthcare providers in analyzing and comparing their costs and outcomes in care delivery. The platform measures the costs of various care processes and evaluates treatment-specific data, enabling providers to learn from peer institutions and enhance their results. Avant-garde Health partners with leading healthcare providers committed to improving the value of care, offering actionable insights that facilitate better clinical decision-making and promote value-based payment models. The company was inspired by research on value-based healthcare delivery conducted at Harvard Business School.
Homeward
Series A in 2022
Homeward is focused on transforming healthcare services for the 60 million Americans residing in rural areas. The company utilizes multidisciplinary care teams that operate both virtually and through mobile care units, ensuring comprehensive and accessible healthcare. Homeward employs in-home remote monitoring technology to enhance patient connections to high-quality and affordable care. By partnering with Medicare Advantage plans, the organization assumes full financial risk for its members, aiming to improve health outcomes while reducing costs. Through these initiatives, Homeward seeks to provide effective support to Medicare-eligible beneficiaries in underserved communities.
Story Health
Series A in 2022
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtualized clinical care software tools aimed at aiding healthcare specialists, particularly neurologists and primary care physicians. The company offers a comprehensive healthcare technology platform that includes virtual patient programs, therapy management, and analytics designed to bridge the gap between clinical evidence and patient experiences. By utilizing data from high-frequency sources, Story Health empowers clinicians to better understand medical situations and make informed decisions regarding the physiological impacts of diseases and therapies. Through its innovative approach, Story Health enhances the ability of specialists to deliver effective patient care.
Equip Health
Series B in 2022
Equip is a virtual program helping families recover from eating disorders at home with comprehensive, gold-standard care created by experts in the field and people in recovery. Equip’s five-person care teams include dieticians, physicians, therapists, and mentors who deliver wrap-around support to provide families progress and lasting recovery. Kristina Saffran and Erin Parks co-founded the company in San Diego, California in 2019.
Ro
Venture Round in 2022
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.
Dewpoint Therapeutics
Series C in 2022
Dewpoint Therapeutics is a Boston-based biotech company focused on the research and development of treatments targeting biomolecular condensates to address various diseases, including cancer, neurodegenerative disorders, and immunological conditions. Founded in 2018, the company employs an innovative drug platform that utilizes machine-learning-based image analysis for visualizing condensates. This technology supports an engine of engineered cell lines designed to track and mitigate harmful protein sequestration. By leveraging its proprietary platform, Dewpoint seeks to facilitate drug discovery across a wide range of medical indications and collaborates with leading academic and pharmaceutical partners to enhance the accessibility of new therapies for unmet healthcare needs.
Casana
Series B in 2022
Casana is a healthcare technology company based in Rochester, New York, that specializes in in-home cardiac health monitoring solutions. Its flagship product, the Heart Seat, is a cloud-connected toilet seat designed to allow patients to effortlessly monitor critical health metrics such as heart rate, blood pressure, blood oxygenation, and cardiac output from the comfort of their homes. The Heart Seat integrates three key sensors: a single-lead ECG for measuring the heart's electrical activity, PPG sensors that assess blood volume, and BCG sensors that track the mechanical activity of the heart. This innovative device aims to assist medical teams in managing chronic conditions by providing continuous, reliable health data outside traditional healthcare settings. Casana's technology is focused on fostering proactive health management and improving patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.